Literature DB >> 6639841

Serum protein binding of propylthiouracil.

J P Kampmann, J E Mølholm Hansen.   

Abstract

Serum protein binding of propylthiouracil (PTU) was measured by ultrafiltration in healthy and hyperthyroid patients. The serum protein binding in 12 euthyroid subjects was 76.2 +/- 1.2% (mean +/- s.d.), not significantly different from the values in 10 hyperthyroid patients: 76.6 +/- 1.3% Binding was unaffected by incubation time and temperatures between 25 and 37 degrees C, but increased from 76.5 to 79.1% when pH changed from 7.4 to 7.9. PTU is predominantly bound to albumin with two classes of binding groups with different number of binding sites and affinity. Displacement experiments showed interaction with acetylsalicylic acid, warfarin and phenylbutazone, but not with antipyrine and nortriptyline or other basic drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6639841      PMCID: PMC1428056          DOI: 10.1111/j.1365-2125.1983.tb02214.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

2.  A graphic method for the determination and presentation of binding parameters in a complex system.

Authors:  H E Rosenthal
Journal:  Anal Biochem       Date:  1967-09       Impact factor: 3.365

3.  Plasma protein binding of tricyclic anti-depressants in man.

Authors:  O Borgå; D L Azarnoff; G P Forshell; F Sjöqvist
Journal:  Biochem Pharmacol       Date:  1969-09       Impact factor: 5.858

4.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07

5.  Studies of propylthiouracil using a newly developed radioimmunoassay.

Authors:  D S Cooper; V C Saxe; F Maloof; E C Ridgway
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

6.  Characteristics of protein binding of Thiobarbiturates and 6-n-propyl-2-thiouracil.

Authors:  T Sakurai; S Tsuchiya; H Matsumaru
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-02       Impact factor: 1.645

Review 7.  Protein binding of cardiac glycosides in disease states.

Authors:  L Storstein
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

8.  Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism.

Authors:  J G Kelly; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

9.  Propylthiouracil in human milk. Revision of a dogma.

Authors:  J P Kampmann; K Johansen; J M Hansen; J Helweg
Journal:  Lancet       Date:  1980-04-05       Impact factor: 79.321

10.  Excretion of methimazole in human milk.

Authors:  K Johansen; A N Andersen; J P Kampmann; J M Mølholm Hansen; H B Mortensen
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

View more
  3 in total

1.  Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy.

Authors:  F Azizi; M E Khamseh; M Bahreynian; M Hedayati
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

2.  Extrapolating In Vitro Screening Assay Data for Thyroperoxidase Inhibition to Predict Serum Thyroid Hormones in the Rat.

Authors:  Iman Hassan; Hisham El-Masri; Jermaine Ford; Amanda Brennan; Sakshi Handa; Katie Paul Friedman; Mary E Gilbert
Journal:  Toxicol Sci       Date:  2020-02-01       Impact factor: 4.109

3.  Mechanistic Computational Model for Extrapolating In Vitro Thyroid Peroxidase (TPO) Inhibition Data to Predict Serum Thyroid Hormone Levels in Rats.

Authors:  Sakshi Handa; Iman Hassan; Mary Gilbert; Hisham El-Masri
Journal:  Toxicol Sci       Date:  2021-08-30       Impact factor: 4.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.